| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2004 | WO2002028352A3 A modulator of antiestrogen pharmacology |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030106 Novel compounds and process |
| 02/12/2004 | US20040030099 Regulation of human patched-like protein |
| 02/12/2004 | US20040030097 Peptide mimetics of type I cytokine molecules such as interleukin 4, (IL-4), human growth hormone (HGH) and interleukin 2 (IL-2) |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029823 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029812 Skin disorders; aging resistance |
| 02/12/2004 | US20040029811 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029805 Prevention and treatment of nonalcoholic fatty liver disease (NAFLD) by antagonism of the receptor to glucose-dependent insulinotropic polypeptide (GIP) |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029802 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029800 Remedies for obesity and obesity-associated diseases and method of evaluating these remedies |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029798 Synergistic mixture of tissue plasminogen activator and heparin; cardiovascular disorders |
| 02/12/2004 | US20040029796 Administering polypeptide; cardiovascular disorders |
| 02/12/2004 | US20040029795 Gene which modulate gene expression of protein |
| 02/12/2004 | US20040029794 Immobilizated growth hormone releasing factor |
| 02/12/2004 | US20040029792 Isolation nucleic acids; determination, measurement, calibration; genetic engineering |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029788 Methods and compositions for the treatment of diseases of the eye |
| 02/12/2004 | US20040029787 Use of substances with oxytocin activity against climacteric disorders |
| 02/12/2004 | US20040029786 Treatment of ulcerative colitis by introducing CEP antigen composition |
| 02/12/2004 | US20040029785 Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029783 Prevention, therapy of respiratory system disorders; administering to humans, animals |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029779 Enzyme replacement therapy; gene therapy; preenzyme moderation of cell surface |
| 02/12/2004 | US20040029778 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 02/12/2004 | US20040029776 Hydroxyethyl starch - containing polypeptide compositions |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
| 02/12/2004 | US20040029277 Oligonucleotides specifically hybridizable with nucleic acids encoding Nitrogen Assimilation Control (NAC); for treating hyperproliferative disease, neurological disorders and aberrant apoptosis |
| 02/12/2004 | US20040029274 Antisense modulation of EDG5 expression |
| 02/12/2004 | US20040029273 Endothelial differentiation gene 1 (EDG1); using antisense compounds for modulation of EDG1 expression and for treatment of diseases associated with expression of EDG1 |
| 02/12/2004 | US20040029248 Chromodomain, Helicase, DNA-binding (CHD) |
| 02/12/2004 | US20040029245 Used in preventing, ameliorating, or correcting dysfunctions or diseases including cancer, diabetes, and obesity |
| 02/12/2004 | US20040029226 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029222 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029220 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029182 For diagnosis/therapy of colorectal cancer |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029169 Nogo Receptor (NgR)-p75; myelins; for drug screening; cell-free |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029158 HOP - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029148 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029140 Therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these proteins |
| 02/12/2004 | US20040029136 Diagnosing, treating, or preventing disorders associated with aberrant expression of lipid metabolism molecules (LMM) |
| 02/12/2004 | US20040029134 P53-associated Parkin-like cytoplasmic protein, and related compositions and methods |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029125 Diagnosis, therapy, prevention autoimmune diseases; genetic engineering; culture product; reducing gene expression |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029116 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028736 Macromolecules; oral administering; mixture of active material and aromatic alcohol |
| 02/12/2004 | US20040028733 Therapy for fertility disorders; stabilized follicle stimulating hormone |
| 02/12/2004 | US20040028717 Wound healing agents; generating cells in situ; contacting tissues; cell differentiation; surgery; tissue engineering |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028706 Neuralgia pain treatment by peripheral administration of a neurotoxin |
| 02/12/2004 | US20040028705 Mutants of clostridium difficile toxin B and methods of use |
| 02/12/2004 | US20040028704 Administering botulinum toxin |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028682 Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix |
| 02/12/2004 | US20040028680 Complexing fibroblast growth factor ; controlling elimination from cell |
| 02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/12/2004 | US20040028675 Compositions for the treatment of lupus |
| 02/12/2004 | US20040028674 Biological materials and the use thereof for the treatment of disease |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028670 Activated protein C formulations |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028654 Protamine-adenoviral vector complexes and methods of use |
| 02/12/2004 | US20040028651 Composition and methods of using hiv vpr |
| 02/12/2004 | US20040028649 Regenerating cells |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10234739A1 New interfering splice variant of human p53 protein, useful for identifying modulators of p53 function, and potential anticancer agents |
| 02/12/2004 | DE10234422A1 Antibakterielle Ester-Makrozyklen Antibacterial ester macrocycles |
| 02/12/2004 | DE10234192A1 Verwendung von Erythropoetin Use of erythropoietin |
| 02/12/2004 | DE10233516A1 Cellular method for identifying modulators of target molecules, useful in screening for pharmaceuticals, from effects of test compounds on both cell growth and reporter expression |
| 02/12/2004 | DE10232621A1 Für ein Enzym Delta-12-Desaturase kodierende Nukleinsäuresequenz, zugehöriges Polypeptid und Verwendung von beiden For an enzyme delta-12 desaturase-encoding nucleic acid sequence associated polypeptide and use of both |